TAC3 and hypogonadotropic hypogonadism: Patients with loss-of-function mutation in neurokinin B (TAC3) and its receptor (TAC3R) show hypogonadotropic hypogonadism characterized by failure to progress through puberty (Topaloglu et al., 2009).